Novo Nordisk Lobbies Up to Win Medicare Coverage of Its Weight Loss Drugs
The maker of Ozempic and Wegovy has recently hired a dozen new lobbyists to work on the issue of obesity and medication coverage.
The maker of Ozempic and Wegovy has recently hired a dozen new lobbyists to work on the issue of obesity and medication coverage.
A new draft bill from Sens. Carper and Capito would exempt thousands of PFAS substances from regulation.
More than one in four senators is invested in the fossil fuel industry as the Senate strips major climate programs from the reconciliation bill.